headerPicture

Contract Services - Overview

Your leading expert for services providing industrial protein expression strain and process development


Your Pichia service provider



VTU Technology is a leading contract research and development company providing fast-track generation of high-performance, industrial protein production strains for pharmaceutical companies and other protein manufacturers.

The company applies its exclusive cutting-edge Pichia pastoris protein expression platform and offers expertise and services, which span the entire range from gene or sequence to highly productive expression strains, small scale processes and product samples, in minimum time.


Your leading provider for the development of high performance protein expression strains and processes

With its proprietary technologies and sophisticated know-how, VTU has developed an unmatched track record providing its customers a wide array of different protein formats including:


  • serum proteins
  • cytokines
  • Fabs
  • antibody derived fragments
  • scaffold proteins
  • fusion proteins
  • enzymes


VTU´s entire comprehensively characterized technology platform is highly appealing for the cost-effective production of biopharmaceuticals, enzymes and other recombinant proteins used for diverse industrial applications.

VTU researchers apply cutting-edge technologies and time saving procedures to maximize both throughput and output and therefore drastically shorten the development time from the gene to gram quantities of different proteins.
 
VTU Technology provides effective solutions for economic protein production accompanied by sound technology transfer and comprehensive documentation ensuring regulatory compliance.


 

Specialized Services


  • Gene design and cloning
  • Development of customized high performance expression strains at unrivaled speed
  • Validation of screening results (1L-fermentations)
  • Process development and optimization
  • Small scale production of non-GMP material (5L)
  • Scale-up and GMP manufacturing through a collaboration with Boehringer Ingelheim
  • Sound technology transfer to our customers supporting regulatory filings


 

Advantages


  • Fast-track development of high performance, industrial protein production strains
  • Valid and scalable results in minimum time
  • Short and flexible project timelines with customized project design
  • High throughput, high output
  • Typical expression levels of 2 to more than 10 g/L (peak expression level of 20 g/L) within weeks
  • FTO certified, well documented technology platform
  • Full documentation to support your regulatory filings